Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, as well as phenotypic variability. The genotype-phenotype relationship in ADPKD is not completely understood. Here, we studied 741 patients with ADPKD from 519 pedigrees in the Genkyst cohort and confirmed that renal survival associated with PKD2 mutations was approximately 20 years longer than that associated with PKD1 mutations. The median age at onset of ESRD was 58 years for PKD1 carriers and 79 years for PKD2 carriers. Regarding the allelic effect on phenotype, in contrast to previous studies, we found that the type of PKD1 mutation, but not its position, correlated strongly with renal survival. The median age at onset of ESRD was 55 years for carriers of a truncating mutation and 67 years for carriers of a nontruncating mutation. This observation allows the integration of genic and allelic effects into a single scheme, which may have prognostic value.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665389PMC
http://dx.doi.org/10.1681/ASN.2012070650DOI Listing

Publication Analysis

Top Keywords

type pkd1
8
pkd1 mutation
8
genic allelic
8
renal survival
8
median age
8
age onset
8
onset esrd
8
esrd years
8
years carriers
8
years
5

Similar Publications

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder leading to end-stage renal disease. ADPKD arises from mutations in the and genes, which encode polycystin 1 (PC1) and polycystin 2 (PC2), respectively. PC2 is a non-selective cation channel, and disease-linked mutations disrupt normal cellular processes, including signaling and fluid secretion.

View Article and Find Full Text PDF

Objective: This study evaluated the accuracy of non-invasive prenatal testing (NIPT-SGDs) for dominant monogenic genetic diseases associated with fetal structural abnormalities and to assess the feasibility of clinical application.

Methods: Pregnant women requiring prenatal diagnosis due to fetal structural abnormalities were enrolled. Maternal peripheral blood was analyzed for cell-free DNA (cfDNA) using coordinative allele-aware target enrichment sequencing (COATE-seq).

View Article and Find Full Text PDF
Article Synopsis
  • Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder leading to kidney cysts and eventual renal failure, primarily caused by mutations in the PKD1 and PKD2 genes.
  • A case report highlights a unique mutation in the PKD1 gene found in a 56-year-old woman with chronic kidney disease and her niece, who showed early signs of the disease.
  • The discovery of a specific mutation (c.2084_2089del) underscores the importance of ongoing genetic research for better diagnosis and treatment options for ADPKD patients.
View Article and Find Full Text PDF

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and causes significant morbidity, ultimately leading to kidney failure. PKD pathogenesis is characterized by complex and dynamic alterations in multiple cell types during disease progression, hampering a deeper understanding of disease mechanism and the development of therapeutic approaches. Here, we generate a single-nucleus multimodal atlas of an orthologous mouse PKD model at early, mid, and late timepoints, consisting of 125,434 single-nucleus transcriptomic and epigenetic multiomes.

View Article and Find Full Text PDF

Unlabelled: We analyzed the impact of nine previously identified missense variants from our studies, including c.6928G > A p.G2310R, c.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!